Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies

The glucocorticoid (GC) steroid dexamethasone (Dex) is used as a supportive care co-medication for cancer patients undergoing standard care pemetrexed/platinum doublet chemotherapy. As trials for new cancer immunotherapy treatments increase in prevalence, it is important to track the immunological c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Alistair M., McDonnell, Alison M., Lake, Richard A., Nowak, Anna K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839331/
https://www.ncbi.nlm.nih.gov/pubmed/27141331
http://dx.doi.org/10.1080/2162402X.2015.1066062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839331/
https://www.ncbi.nlm.nih.gov/pubmed/27141331
http://dx.doi.org/10.1080/2162402X.2015.1066062

Ejemplares similares